precisionmedicineonline11h
Spur Therapeutics, FDA Align on Phase III Plans for Gaucher Disease Gene Therapy
The FDA has offered positive feedback on possible paths forward for accelerated or traditional approval of FLT201 using data from a single-arm study.
Spur Therapeutics Announces Successful End-of-Phase 2 Meeting with FDA for FLT201, Its Gene Therapy Candidate for Gaucher Disease
FDA aligned on single-arm Phase 3 study to support potential accelerated and full approvalOn track to dose first patient in Phase 3 trial in ...
scmp.com3y
History makers: How Galileo changed astronomy - and got put on trial by the Catholic church
Putting truth on trial Armed with his discoveries, Galileo converted to Copernicanism, the thoughts of Polish astronomer Nicolaus Copernicus (1473-1543), who had proposed that the sun was the ...
Spur Therapeutics Announces Platform and Poster Presentations Highlighting New Clinical Data for FLT201 in Gaucher Disease at Upcoming WORLDSymposium
Additional details on the meeting can be found at the WORLD Symposium website. About Spur Therapeutics Spur Therapeutics is a clinical-stage biotechnology company focused on developing life-changing ...
PBS12y
The Galileo Games
A young Galileo is perched atop the Leaning Tower of Pisa. He is in the middle of his famous experiment—the one in which he shows, by dropping cannonballs of different weights, that all objects ...
Hosted on MSN27d
Galileo Galilei and Stephen Hawking: 300 years apart, united by the cosmos
In 1633, Galileo found himself on trial, accused of heresy for challenging the Church's geocentric dogma. The Inquisition demanded silence. He was forced to recant his findings under threat of ...